INFI
  
  
      
        Infinity Pharmaceuticals, Inc.
      
      
        
          INFI
        
        
      
    
  
          INFI
        
        
      Delisted
    INFI was delisted on the 13th of September, 2023.
94 hedge funds and large institutions have $52.1M invested in Infinity Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
  Increased
  Maintained
  Reduced
  Closed
  more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
98% less call options, than puts
Call options by funds: $26K | Put options by funds: $1.04M
    
      Holders
    
  
  
    
      
        
      
        94
      
    
      
    
  
    
      Holding in Top 10
    
  
  
    
      
        
      
        –
      
    
      
    
  
    
      Calls
    
  
  
    
      
        
      
        $26K
      
    
      
    
  
    
      Puts
    
  
  
    
      
        
      
        $1.04M
      
    
      
    
  
Top Buyers
| 1 | +$3.66M | |
| 2 | +$902K | |
| 3 | +$341K | |
| 4 | 
          
   
    QIM
   
  
      Quantitative Investment Management
     
    
      
        Charlottesville,
      
      
        Virginia
      
     
   | 
        +$207K | 
| 5 | 
          
   
      Tudor Investment Corp
     
    
      
        Stamford,
      
      
        Connecticut
      
     
   | 
        +$197K | 
Top Sellers
| 1 | -$3.02M | |
| 2 | -$3M | |
| 3 | -$571K | |
| 4 | 
          
   
    CS
   
  
      Credit Suisse
     
    
      
        Zurich,
      
      
        Switzerland
      
     
   | 
        -$302K | 
| 5 | 
          
   
      Renaissance Technologies
     
    
      
      
        New York
      
     
   | 
        -$217K |